摘要
目的探讨进行急诊PCI的急性心梗患者在接受阿托伐他汀序贯治疗后心功能的改善情况。方法选择60例2015年3月~2016年8月的本院急性心肌梗死患者为研究对象,随机分为两组各30例,观察组采用阿托伐他汀序贯疗法,对照组采用阿托伐他汀常规疗法,观察两组患者的心肌酶指标、血脂指标、不良反应情况、生活质量评分、不良反应率。结果治疗后,观察组心肌酶以及血脂异常情况得到良好纠正,不良反应率仅为6.67%,不良反应的发生例数少,生活质量4项评分较对照组高,相比对照组具有绝对优势(P<0.05)。结论对急诊PCI急性心梗患者实施阿托伐他汀序贯疗法后,其心功能的改善情况较优,影响作用非常显著。
Objective To investigate the improvement of cardiac function in patients with acute myocardial infarction （PCI） who underwent sequential therapy with atorvastatin. Methods 60 cases in March 2015 to August 2016 in our hospital patients with acute myocardial infarction were collected and to do research, who were randomly divided into 2 groups （each 30 cases）, observation group adopted Atorvastatin sequential therapy, control group adopted Atorvastatin routine therapy,compared with the two groups of patients with myocardial enzymes, blood lipids, adverse reactions, quality of life score, adverse reaction rate. Results After treatment, the myocardial enzymes and dyslipidemia in the observation group were well corrected, the adverse reaction rate was only 6.67%, fewer cases of adverse reactions oc- curred, the quality of life was 4 points higher than the control group, compared with the control group had absolute su- periority （P〈0.05）. Conclusion After Sequential therapy of atorvastatin in patients with acute PCI for acute myocardial infarction, patients with improved heart function is better, the impact is very significant.
出处
《中国现代医生》
2017年第10期91-93,共3页
China Modern Doctor
关键词
阿托伐他汀
急诊PCI
急性心梗
心功能
影响作用
Atorvastatin
Emergency PCI
Acute myocardial infarction
Cardiac function
Effect
